Dr. Sada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2002 Holcombe Blvd
Dept Of Hematology & Oncology Va 111 H
Houston, TX 77030Phone+1 713-794-7111Fax+1 713-794-7733- Is this information wrong?
Education & Training
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011- Baylor College of MedicineResidency, Internal Medicine, 2005 - 2008
University of Rochester School of Medicine and DentistryClass of 2005
Certifications & Licensure
TX State Medical License 2011 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Meclizine for Hepatocellular Carcinoma Start of enrollment: 2017 Oct 13
Publications & Presentations
PubMed
- Harnessing physical activity monitoring and digital biomarkers of frailty from pendant based wearables to predict chemotherapy resilience in veterans with cancer.Cay, G., Dehghan Rouzi, M., Uddin Atique, M., Rodriguez, N., Azarian, M., Finco, M., Najafi, B., Sada, Y., Yellapragada, S.> ;Scientific Reports. 2024 Jan 31
- Study protocol: maintaining preventive care during public health emergencies through effective coordination.Sylvia J Hysong, Traber Davis Giardina, Jennifer Freytag, Richard SoRelle, Daniel R Murphy, Jeffrey A Cully, Yvonne H Sada, Amber B Amspoker> ;Implementation Science Communications. 2023 Nov 27
- Survival outcomes in veterans with hepatocellular carcinoma, with and without HIV infection.Yvonne H Sada, Wilson L da Costa Jr, Jennifer R Kramer, Elizabeth Y Chiao, Efthalia Zafeiropoulou, Yongquan Dong, Liang Chen, Bich N Dang> ;AIDS. 2023 Jul 15
- Join now to see all
Press Mentions
Resilient Cancer Patient Grateful for Houston VAMarch 20th, 2023- A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal CancerApril 4th, 2024
Hospital Affiliations
St. Luke's Health - Baylor St. Luke's Medical CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
